Parkinson's disease (PD) is a neurodegenerative disorder that primarily affects dopamine-producing neurons in the substantia nigra. This article aims to provide a comprehensive understanding of the disease, its diagnosis, and management strategies.
The pathogenesis of PD is multifactorial, involving both genetic and environmental factors. The hallmark pathological feature is the loss of dopaminergic neurons in the substantia nigra pars compacta, leading to striatal dopamine deficiency. This results in the classic motor symptoms of PD: bradykinesia, rigidity, and rest tremor.
Diagnosis of PD is primarily clinical, based on the presence of cardinal motor symptoms and the absence of atypical features or secondary causes. The Movement Disorder Society (MDS) clinical diagnostic criteria for PD is a widely accepted tool. Neuroimaging, although not routinely used, can aid in uncertain cases.
The management of PD is multidimensional, involving pharmacologic and non-pharmacologic interventions. Levodopa remains the most effective treatment for motor symptoms. Dopamine agonists, MAO-B inhibitors, and deep brain stimulation are other treatment options. Non-pharmacologic interventions include physical therapy and occupational therapy. Patient education and support are crucial components of care.
Understanding the pathophysiology, diagnosis, and management of Parkinson's disease is fundamental for healthcare professionals. While there is currently no cure, early diagnosis and comprehensive management can significantly improve the quality of life of patients. Continued research and advancements in therapy offer hope for future breakthroughs in the fight against this debilitating disease.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation